.

ad test

Friday, February 3, 2012

But They Still Suck

So the Susan G. Komen Race for the Cure has sort of backed down:

The Susan G. Komen for the Cure Foundation announced Friday that it would revise a new policy that barred the organization from funding Planned Parenthood, a move that had thrust the breast cancer foundation into a national controversy.

Komen apologized “to the American public for recent decisions that cast doubt upon our commitment to our mission of saving women’s lives.”

The foundation said that Planned Parenthood would now be eligible to apply for grants. It did not, however, address other reasons Komen has cited for why it might choose not to approve such grants.

“Our original desire was to fulfill our fiduciary duty to our donors by not funding grant applications made by organizations under investigation,” a Friday statement said. “We will amend the criteria to make clear that disqualifying investigations must be criminal and conclusive in nature and not political. That is what is right and fair.”

“We will continue to fund existing grants, including those of Planned Parenthood, and preserve their eligibility to apply for future grants, while maintaining the ability of our affiliates to make funding decisions that meet the needs of their communities,” the statement continues.
What they are saying that they aren't cancelling current grants, which they never said they would, and Planned Parenthood can apply for grants next year, but there are "no promises".

There may be grants to Planned Parenthood next year, but they will eventually cut them off, assuming that these folks aren't (hopefully) a dead corporatist charity walking.

Btw, in the, "It sucks when an angel pees down the barrel of your rifle," department, a documentary, called "Pink Ribbons, Inc.," is hitting theaters in Canada, and film festivals in the United States as I am typing this.

The film alleges that Komen is "Pink Washing" companies that are suspected of exposing the population to carcinogens that might cause breast cancer, among other things.

No comments: